End-of-day quote
INDONESIA S.E.
23:00:00 18/03/2024 GMT
|
5-day change
|
1st Jan Change
|
1,715
IDR
|
+3.63%
|
|
-.--%
|
+471.67%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,048,179
|
3,216,189
|
2,448,144
|
3,720,219
|
7,860,462
|
3,600,212
|
Enterprise Value (EV)
1 |
2,960,105
|
3,237,155
|
3,976,005
|
5,379,551
|
9,979,738
|
6,247,480
|
P/E ratio
|
-31.9
x
|
-42.5
x
|
-170
x
|
22.5
x
|
-177
x
|
-93.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.78
x
|
3.21
x
|
1.91
x
|
1.93
x
|
4.06
x
|
1.44
x
|
EV / Revenue
|
3.67
x
|
3.23
x
|
3.1
x
|
2.8
x
|
5.16
x
|
2.5
x
|
EV / EBITDA
|
-567
x
|
221
x
|
35.3
x
|
13.7
x
|
44.1
x
|
17.3
x
|
EV / FCF
|
321
x
|
-27.2
x
|
-8.05
x
|
-1,065
x
|
-22.2
x
|
-11.5
x
|
FCF Yield
|
0.31%
|
-3.67%
|
-12.4%
|
-0.09%
|
-4.5%
|
-8.69%
|
Price to Book
|
1.66
x
|
1.81
x
|
1.4
x
|
1.93
x
|
4.15
x
|
1.94
x
|
Nbr of stocks (in thousands)
|
12,000,705
|
12,000,705
|
12,000,705
|
12,000,705
|
12,000,705
|
12,000,705
|
Reference price
2 |
254.0
|
268.0
|
204.0
|
310.0
|
655.0
|
300.0
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
806,031
|
1,002,002
|
1,283,799
|
1,924,453
|
1,934,164
|
2,503,174
|
EBITDA
1 |
-5,222
|
14,680
|
112,571
|
391,314
|
226,422
|
360,990
|
EBIT
1 |
-85,303
|
-61,032
|
9,568
|
241,799
|
26,364
|
105,145
|
Operating Margin
|
-10.58%
|
-6.09%
|
0.75%
|
12.56%
|
1.36%
|
4.2%
|
Earnings before Tax (EBT)
1 |
-96,978
|
-66,323
|
191.4
|
156,420
|
-42,087
|
-31,291
|
Net income
1 |
-95,419
|
-75,670
|
-14,381
|
165,308
|
-44,315
|
-38,490
|
Net margin
|
-11.84%
|
-7.55%
|
-1.12%
|
8.59%
|
-2.29%
|
-1.54%
|
EPS
2 |
-7.951
|
-6.305
|
-1.198
|
13.77
|
-3.693
|
-3.207
|
Free Cash Flow
1 |
9,224
|
-118,914
|
-493,965
|
-5,052
|
-449,095
|
-542,620
|
FCF margin
|
1.14%
|
-11.87%
|
-38.48%
|
-0.26%
|
-23.22%
|
-21.68%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
20,966
|
1,527,861
|
1,659,333
|
2,119,276
|
2,647,268
|
Net Cash position
1 |
88,074
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.428
x
|
13.57
x
|
4.24
x
|
9.36
x
|
7.333
x
|
Free Cash Flow
1 |
9,224
|
-118,914
|
-493,965
|
-5,052
|
-449,095
|
-542,620
|
ROE (net income / shareholders' equity)
|
-5.51%
|
-4.19%
|
-0.82%
|
8.99%
|
-2.31%
|
-2.04%
|
ROA (Net income/ Total Assets)
|
-2.18%
|
-1.3%
|
0.16%
|
3.28%
|
0.31%
|
1.16%
|
Assets
1 |
4,380,413
|
5,801,119
|
-8,965,478
|
5,041,730
|
-14,285,928
|
-3,325,845
|
Book Value Per Share
2 |
153.0
|
148.0
|
146.0
|
161.0
|
158.0
|
155.0
|
Cash Flow per Share
2 |
18.70
|
19.30
|
52.50
|
58.40
|
93.20
|
42.90
|
Capex
1 |
409,563
|
385,242
|
544,122
|
464,023
|
655,547
|
583,532
|
Capex / Sales
|
50.81%
|
38.45%
|
42.38%
|
24.11%
|
33.89%
|
23.31%
|
Announcement Date
|
01/04/19
|
09/05/20
|
09/06/21
|
25/03/22
|
30/03/23
|
01/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +471.67% | 1.28B | | +18.41% | 83.07B | | -29.08% | 70.89B | | +3.59% | 28.32B | | -7.08% | 17.73B | | +2.07% | 17.43B | | +0.93% | 15.64B | | +6.78% | 13.46B | | +8.40% | 12.82B | | +68.45% | 12.69B |
Other Healthcare Facilities & Services
|